Axel Bode
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 6
- Renal cell carcinoma treatment 1
-
- Radiopharmaceutical Chemistry and Applications 4
- Medical Imaging Techniques and Applications 1
- Co-authors
- Kambiz Rahbar (6 shared papers)M. Claesener (4 shared papers)Martin Bögemann (3 shared papers)Matthias Weckesser (3 shared papers)Lars Stegger (3 shared papers)Anna Yordanova (2 shared papers)Alexander Heinzel (2 shared papers)Matthias Schmidt (2 shared papers)
- Journals
- Journal of Nuclear Medicine (1 paper)Clinical Nuclear Medicine (3 papers)Kölner Universitäts PublikationsServer (Universität zu Köln) (1 paper)
- Partner nations
- Germany
In The Last Decade
Axel Bode
6 papers receiving 332 citations
Peers
Comparison fields: 5 of 23
- Radiology, Nuclear Medicine and Imaging 225
- Pulmonary and Respiratory Medicine 292
- Oncology 88
- Spectroscopy 29
- Cancer Research 13
Countries citing papers authored by Axel Bode
This map shows the geographic impact of Axel Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Bode more than expected).
Fields of papers citing papers by Axel Bode
This network shows the impact of papers produced by Axel Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Bode. The network helps show where Axel Bode may publish in the future.
Co-authors
The 14 scholars most cited alongside Axel Bode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 170 | |
| 2 | 2016 | 147 | |
| 3 | 2016 | 13 | |
| 4 | 2016 | 5 | |
| 5 | Response and tolerability after a single dose of Lu-177-PSMA-617 in patients with metastatic castration resistant prostate cancer: a multicenter Study | 2016 | 1 |
| 6 | Radioligand Therapy with Lu-177-PSMA-617 may improve survival in Patients with Metastatic Prostate Cancer | 2016 | 1 |
About Axel Bode
Axel Bode is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research, Infectious Diseases and Organic Chemistry, having authored 6 papers that have together received 337 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer, Lipids, and Metabolism (2 papers), Renal cell carcinoma treatment (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (225 citations), Pulmonary and Respiratory Medicine (292 citations), Oncology (88 citations), Spectroscopy (29 citations) and Cancer Research (13 citations). Axel Bode has collaborated with scholars based in Germany. Frequent co-authors include Kambiz Rahbar, M. Claesener, Martin Bögemann, Matthias Weckesser, Lars Stegger, Anna Yordanova, Alexander Heinzel, Matthias Schmidt, Nemanja Avramović and Elisabeth Eppard. Their work appears in journals such as Journal of Nuclear Medicine, Clinical Nuclear Medicine and Kölner Universitäts PublikationsServer (Universität zu Köln).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.